Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Mallinckrodt Pharmaceuticals and Endo Inc. are exploring a potential merger that could be valued at about $7 billion, people ...

All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

The stringent action is meant to prevent criticism of quality of drugs produced in the country and to prevent any non-tariff ...

Dublin-headquartered Mallinckrodt is taking over smaller rival Endo and planning to list the combined firm on the New York ...

(Reuters) - Mallinckrodt and Endo, drugmakers with a shared history of facing U.S. opioid litigation, have agreed to merge in ...

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

Drugmakers have warned that a recent rise in the UK’s medicine sales tax has left the country “uninvestable”, as the government prepares for a summit to try to repair relationships with large ...

The pharmaceutical industry is urging the Trump administration and European Union to exclude medical goods from tariff ...